Private Wealth Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Hold
1,548
0.15% 48
2026
Q1
$337K Hold
1,548
0.16% 50
2025
Q4
$354K Buy
1,548
+50
+3% +$11.4K 0.17% 47
2025
Q3
$347K Hold
1,498
0.17% 49
2025
Q2
$278K Hold
1,498
0.15% 57
2025
Q1
$314K Hold
1,498
0.18% 48
2024
Q4
$266K Hold
1,498
0.13% 60
2024
Q3
$296K Hold
1,498
0.15% 54
2024
Q2
$257K Hold
1,498
0.13% 56
2024
Q1
$273K Hold
1,498
0.14% 57
2023
Q4
$232K Hold
1,498
0.13% 53
2023
Q3
$223K Hold
1,498
0.15% 51
2023
Q2
$202K Hold
1,498
0.21% 50
2023
Q1
$239K Hold
1,498
0.33% 47
2022
Q4
$242K Hold
1,498
0.34% 45
2022
Q3
$201K Hold
1,498
0.31% 40
2022
Q2
$229K Hold
1,498
0.28% 41
2022
Q1
$243K Hold
1,498
0.18% 41
2021
Q4
$203K Buy
+1,498
New +$177K 0.14% 41

Other funds holding ABBV

Private Wealth Group's ABBV Position: Q2 2026 in Review

Private Wealth Group held its AbbVie (ABBV) position steady in Q2 2026 at 1,548 shares worth $390K. The position accounts for 0.15% of the portfolio, ranked #48.

Private Wealth Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Wealth Group held 1,548 shares of AbbVie worth $390K as of Q2 2026.
  • Private Wealth Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.15% of Private Wealth Group's portfolio in Q2 2026, its #48 holding.
  • Private Wealth Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Wealth Group's 13F filing for Q2 2026, filed 8 Jul 2026.